Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9579300
APP PUB NO 20140199376A1
SERIAL NO

14184889

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric Nanoparticle form of thyroid hormone agonist, partial agonist or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone analogs, are also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NANOPHARMACEUTICALS LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Faith B Latham, US 12 376
Davis, Paul J Latham, US 46 1128
Mousa, Shaker A Latham, US 73 862

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 28, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00